MedTrace Logo

Increased Femoral Anteversion and Physical Performance

NCT05882981 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2024-01-17

No results posted yet for this study

Summary

It is important to determine how high femoral anteversion, which is one of the lower extremity malalignments, affects physical performance and to what extent it affects the daily life of the individual. As far as we know, there is no study on this subject except for a study conducted by Staheli et al. in 1977. Therefore, the investigators planned to determine whether and to what extent high femoral anteversion has an effect on physical performance in healthy young adults.

Conditions

  • High Femoral Anteversion
  • Muscle Strength
  • Flexibility
  • Functional Performance
  • Functional Capacity

Interventions

OTHER

Sit and reach test

It will be used to measure the flexibility of the participants.

OTHER

Hand grip strength measurement

Grip strength will be evaluated with a hand dynamometer in the position recommended by the American Association of Hand Therapists.

OTHER

Back-leg-chest muscle strength measurement

An analog Back Leg-Chest dynamometer will be used to evaluate general muscle strength.

OTHER

Functional performance

Single-leg and double-leg horizontal jump test will be used to evaluate lower extremity functional performance. The tests will be carried out according to the Eurofit test battery (Council of Europe, 1988).

OTHER

Functional capacity

Functional capacity will be evaluated with six minute walk test according to the ATS criteria.

Sponsors & Collaborators

  • Bezmialem Vakif University

    lead OTHER

Eligibility

Min Age
17 Years
Max Age
26 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-20
Primary Completion
2023-12-20
Completion
2024-01-14

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05882981 on ClinicalTrials.gov